GlassScriptPhysician profile
Stephan Pavlos
NPI 1619952439
$1,560.49
in general payments reported to CMS, 2019-2025
18 companies · $143 in 2025
The $143 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $65.95 · 2020: $141 · 2021: $115 · 2022: $288 · 2023: $510 · 2024: $297 · 2025: $143.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $950.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $950.24 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $542.77 | 2020-2025 | Lifevest |
| Boehringer Ingelheim Pharmaceuticals, INC. | $168.61 | 2022-2024 | Jardiance |
| Pfizer INC. | $139.38 | 2019-2024 | |
| E.R. Squibb & Sons, L.L.C. | $138.13 | 2021-2025 | Camzyos, Eliquis |
| Amgen INC. | $85.24 | 2021-2023 | Repatha |
| Edwards Lifesciences Corporation | $77.23 | 2025 | |
| Janssen Pharmaceuticals, INC | $66.90 | 2022-2024 | Xarelto |
| Boston Scientific Corporation | $51.72 | 2023 | Bodyguardian |
| Astrazeneca Pharmaceuticals LP | $49.35 | 2020-2022 | |
| Abbott Laboratories | $42.99 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $41.80 | 2024-2025 | |
| Amarin Pharma, INC. | $37.96 | 2019-2021 | |
| Lexicon Pharmaceuticals, INC. | $30.25 | 2023 | Inpefa |
| Kestra Medical Technology Services, INC. | $23.92 | 2023 | Assure Wcd |
| Cvrx, INC. | $18.33 | 2022 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kiniksa Pharmaceuticals International, Plc | $16.93 | 2024 | Arcalyst |
| Medtronic, INC. | $14.51 | 2022 | |
| Medtronic Vascular, INC. | $14.47 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephan Pavlos listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.